利巴韦林联合药物治疗小儿支气管炎的价值分析

摘要

Objective To study the value of ribavirin combine with drugs to treat infantile bronchitis. Methods Selected 80 cases with infantile bronchitis were randomly divided into treatment group and control group, each group of 40 cases, the control group given ribavirin therapy alone, the treatment group on the basis of treatment with hydrochloric acid ammonia bromine rope, compared with the curative effect. Results The total curative effect of treatment group with drug therapy was higher than the control group, P<0.05, had difference statistically signiifcance. The treatment group with clinical improvement was shorter than the control group, P<0.05, had difference statistically significance. Two groups had no obvious adverse reactions. Conclusion Rribavirin in combination with hydrochloric acid ammonia bromine line value ideal drug for the treatment of infantile bronchitis, alone with ribavirin therapy can improve curative effect, promote clinical symptoms subsided, and safe and reliable.%目的：探讨利巴韦林联合药物治疗小儿支气管炎的价值。方法将80例小儿支气管炎患儿随机分为治疗组和对照组，每组各40例，对照组给予单独利巴韦林治疗，治疗组在此基础上加用盐酸氨溴索治疗，对比疗效。结果治疗组患儿药物治疗总疗效高于对照组， P＜0.05，差异具有统计学意义。治疗组患儿临床表现改善时间短于对照组，P＜0.05，差异具有统计学意义。两组均无明显不良反应。结论利巴韦林联合盐酸氨溴索药物治疗小儿支气管炎的价值较理想，对比单独使用利巴韦林治疗，能够提高疗效，促进临床症状消退，且安全可靠。